Skip to Main Content

Paper Details

An open-label, dose-ranging trial of AL 721 in patients with persistent generalized lymphadenopathy and AIDS-related complex.
4
1991
AIDS-related complex, AL, HIV, HIV p24 antigenemic, HIV-infected, T, T-lymphocyte subset, cholesterol, human immunodeficiency virus, men, patients, persistent generalized lymphadenopathy, triglyceride

Datasets